Medical disclaimer

This site is an educational reference about tesamorelin. It is not medical advice, it does not create a clinician relationship, and it sells no products. Tesamorelin is FDA-approved (Egrifta) to reduce excess abdominal fat in adults with HIV-associated lipodystrophy. Use for general fat loss or anti-aging is off-label, and 'research' tesamorelin vials are not the approved product. The label contraindicates tesamorelin in pituitary or hypothalamic axis disruption, active malignancy, hypersensitivity, and pregnancy, and requires IGF-1 and glucose monitoring during therapy. Decisions about starting, stopping, or continuing tesamorelin, and about any lab result it produces, belong with a licensed clinician who knows your history. If you experience symptoms of a hypersensitivity reaction (rash, hives, flushing, itching), the label's instruction is to stop the drug and seek prompt medical attention. Bring this site's citations to your clinician; do not bring its pages in place of one.